Yazen
Yazen is a Swedish-founded digital obesity clinic providing medically supervised GLP-1 weight loss treatment with multidisciplinary coaching across seven European markets, serving over 37,000 active patients on a monthly subscription model.
- Company typePrivate
- Founded2021
- HeadquartersLund, Sweden
- Headcount251–500
- GTM typeB2C
- OfferingServices
What Yazen does
Yazen is a Swedish digital healthcare company founded in 2021 and headquartered in Lund/Malmö that operates one of Europe's largest digital obesity clinics. The company delivers medically supervised weight loss treatment through a three-phase subscription program (Connect, Change, Clarity) that combines GLP-1/GIP medications with multidisciplinary lifestyle support from physicians, dietitians, psychologists, personal trainers, and dedicated YazenCoaches. Its core technology is the Yazen App, a telemedicine platform enabling patients to track progress, communicate with their care team, access the Yazen Commit learning program, and participate in the Yazen Community.
Yazen generates revenue through monthly subscriptions starting at SEK 995 (~€87), with medication costs billed separately, producing a recurring revenue stream with high customer lifetime value. Patients are acquired primarily through DTC digital channels — SEO, the BMI calculator tool, content marketing, app store listings, and paid social — with marketing investment exceeding €17.8 million in 2025. The company employs 251-500 staff and operates across seven European markets (Sweden, Norway, Denmark, Netherlands, UK, Germany, Spain), serving over 37,000 active patients and reporting 50,000+ success stories with an average 20% body weight loss in the first year.
The business is venture-backed, having raised approximately €22.6 million in equity (€3.1M seed in 2023, €19.5M growth round in 2024) plus a €6.5M debt facility from HSBC Innovation Banking in 2026. The Medstart acquisition in December 2024 expanded Yazen into Denmark and strengthened its Nordic footprint. Leadership includes CEO Fredrik Meurling and Chairman Mikael Hed. Revenue reached approximately €29.4M in 2025 with ARR of SEK 372M, though EBITDA remained negative at -€5.7M due to growth investments.
Yazen firmographics
Firmographics- Name
- Yazen
- Legal name
- Yazen
- Website
- https://yazen.se
- Company type
- Private
- Founded year
- 2021
- Operating status
- Operating
- Headcount range
- 251–500 employees
- Short description
- Yazen is a Swedish-founded digital obesity clinic providing medically supervised GLP-1 weight loss treatment with multidisciplinary coaching across seven European markets, serving over 37,000 active patients on a monthly subscription model.
- Ownership category
- akta.pro rank
Yazen industry classification
Industry- Product category
- Digital Obesity Care
- NAICS
- Other Ambulatory Health Care Services (6219)
- SIC
- Services-Health Services (8000)
- akta.pro primary industry
- Obesity Medicine & Weight Management (HLAKADAL)
Keywords
Where Yazen is headquartered
LocationHeadquarters
- HQ city
- Lund
- HQ country
- Sweden
- HQ region
- Europe
Offices2 records
Markets served
Yazen business model
Business model- GTM type
- B2C
- Offering type
- Services
- Cost components
- Marketing or Sales, Personnel, Operations, Technology or R&D, Others
Revenue model
- Subscription-based treatment services: Yazen generates revenue through monthly subscription fees for its digital obesity treatment program. Patients pay a monthly fee (starting from 995 kr) for access to the medical treatment team, app-based tools, personalized treatment plans, and ongoing support. The subscription model provides recurring revenue with high customer lifetime value. Note: Medication costs are not included in the subscription price.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Subscription | Monthly | Initial Phase (Connect): 995 kr one-time |
| Subscription | Monthly | Ongoing Treatment (Change): From 995 kr/month |
| Subscription | Monthly | Maintenance Phase (Clarity): Custom pricing |
Go-to-market motion2 records
Distribution channels4 records
Marketing channels6 records
Yazen product offering
Product offeringCore offering
Yazen is a digital obesity clinic providing medically supervised weight loss treatment through a subscription-based program that combines GLP-1/GIP analog medications with multidisciplinary lifestyle support (doctors, dietitians, psychologists, personal trainers, and dedicated YazenCoaches). The service is delivered via the Yazen App, structured in three phases (Connect onboarding, Change active treatment, Clarity maintenance), with patients paying a monthly subscription starting at SEK 995 plus separate medication costs.
Product overview
Yazen is a digital obesity clinic offering a unified platform-and-module product architecture. The core product is the Yazen App, which serves as the central hub for patients to access their medical obesity treatment program. The treatment program itself integrates GLP-1/GIP medication with lifestyle coaching and is delivered through three phases (Connect, Change, Clarity). The app supports several add-on modules: YazenCoach (personalized coaching), Yazen Commit (behavioral learning program), and Yazen Community (peer support forums). Together, these components provide end-to-end digitally delivered, medically supervised weight loss care.
Differentiator
Problem solved
Functional benefit
Products and services
- Yazen App Mobile and web application that serves as the central hub for patients to access their Yazen treatment team, track weight-loss progress, chat with coaches and medical staff, use lifestyle tools, and participate in the Yazen Commit learning program. Available on iOS App Store and Google Play for individual patients across Yazen's seven European markets.
- Medical Obesity Treatment Program A medically supervised weight-loss subscription program combining approved GLP-1/GIP analog medications with lifestyle interventions, supported by a multidisciplinary team of physicians, dietitians, psychologists, personal trainers and dedicated YazenCoaches. Delivered in three phases — Connect (onboarding with blood test and consultation), Change (active treatment from SEK 995/month), and Clarity (maintenance) — for adults with BMI ≥27 across Sweden, Norway, Denmark, Netherlands, UK, Germany, and Spain.
Quantifiable outcome
- Patients lose an average of 20% of their body weight during the first year of treatment.
- +3 more outcomes
Companies that use Yazen
Customer profileNamed customers3 records
Segments2 records
Ideal customer profiles1 record
Yazen technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature4 records
Yazen partnerships and signals
Strategic signalPartnerships
One partnership is on record.
- MedstartcoreYazen acquired Danish healthcare company Medstart to expand into Denmark and strengthen its presence in Norway. The acquisition follows Yazen's €19.5 million investment and aims to integrate Medstart into its European expansion plan by 2025. This acquisition supports Yazen's focus on digital solutions and innovative medications to improve obesity care across Europe.
Scale indicators11 records
Recent moves8 records
Expansion highlights6 records
Yazen competitors and assessment
Company assessmentBroad incumbents
- Kry (Livi): Kry is a leading European telehealth provider headquartered in Sweden, offering video consultations with doctors across multiple specialties. Comparable to Yazen as a Swedish-founded digital health platform serving multiple European countries.
- WeightWatchers (WW International): WeightWatchers is a legacy global weight management brand that has pivoted to include GLP-1 medication access via telehealth. Comparable to Yazen in target customer and weight loss offering, but operates at much larger scale with a broader portfolio.
Direct peers
- Ro: Ro is a US telehealth company operating across multiple verticals including weight loss through its Body Program. Overlaps with Yazen in its D2C telemedicine + medication model targeting chronic conditions.
- Hims & Hers Health: Hims & Hers is a large US telehealth platform that has expanded into weight loss via GLP-1 prescriptions. Comparable to Yazen as a digital-first subscription provider combining telemedicine with prescription medication for obesity.
- Noom: Noom is a D2C digital weight loss platform combining coaching, app-based tools, and now GLP-1 medication support. Directly comparable to Yazen in its subscription-based digital weight management model with multidisciplinary coaching.
- Found: Found is a US-based digital weight loss company offering GLP-1 medication combined with lifestyle coaching via an app-based subscription. Closely mirrors Yazen's combined medication + coaching D2C model.
- Oviva: Oviva is a European digital health provider offering app-based lifestyle and weight management programs, often reimbursed by insurers. Comparable to Yazen as a digital obesity treatment provider active across multiple European markets.
- Calibrate: Calibrate is a digital metabolic health company focused on sustainable weight loss using GLP-1 medications alongside coaching. Comparable to Yazen in its medically supervised, app-driven subscription obesity treatment model.
Regional players
- Zava: Zava is a European online doctor and pharmacy service operating across the UK, Germany, France, and Ireland. Comparable to Yazen as a D2C digital health platform offering prescription treatments across multiple European markets.
- Doktor.se: Doktor.se is a Swedish digital primary care provider offering app-based doctor consultations. Comparable to Yazen in its Swedish telemedicine roots and digital healthcare delivery model, though focused on broader primary care.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat6 records
Key risks6 records
Key highlights7 records
Customer concentration
Yazen social profiles
Digital presenceYazen compliance and trust
Trust signalCompliance1 record
Yazen financial estimates
Financial estimateRevenue estimate
Valuation estimate
Yazen leadership team
Management profileNumber of profiles
Profiles2 records
Yazen subsidiaries and ownership
Company hierarchySubsidiaries1 record
Yazen funding detail
Funding detailFunding overview
Funding rounds5 records
Investors11 records
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Yazen M&A and investment
M&A and investmentM&A1 record
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Yazen
What does Yazen do?
Yazen is a digital obesity clinic providing medically supervised weight loss treatment through a subscription-based program that combines GLP-1/GIP analog medications with multidisciplinary lifestyle support (doctors, dietitians, psychologists, personal trainers, and dedicated YazenCoaches). The service is delivered via the Yazen App, structured in three phases (Connect onboarding, Change active treatment, Clarity maintenance), with patients paying a monthly subscription starting at SEK 995 plus separate medication costs.
Is Yazen a public or private company?
Yazen is a private company. It is classified as venture growth investor backed and is currently operating.
When was Yazen founded?
Yazen was founded in 2021. It employs 251 to 500 people.
Where is Yazen based?
Yazen is headquartered in Lund, Sweden, in the Europe region.
How does Yazen make money?
One revenue line is on record: subscription-based treatment services.
Who are Yazen's main competitors?
Broad incumbents on record are Kry (Livi) and WeightWatchers (WW International). Direct peers are Ro, Hims & Hers Health, Noom, Found, Oviva and Calibrate. Regional players are Zava and Doktor.se.
Does Yazen have an API?
No public API is recorded for Yazen.
What industry is Yazen in?
Yazen's product category is Digital Obesity Care. Its primary akta.pro industry code is HLAKADAL, Obesity Medicine & Weight Management. Its NAICS code is 6219 and its SIC code is 8000.